AssuredPartners Investment Advisors LLC Acquires New Holdings in HCA Healthcare, Inc. (NYSE:HCA)

AssuredPartners Investment Advisors LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 990 shares of the company's stock, valued at approximately $297,000.

Several other hedge funds have also recently made changes to their positions in HCA. Whipplewood Advisors LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at about $31,000. Tidemark LLC bought a new stake in HCA Healthcare in the fourth quarter worth $36,000. Legacy Investment Solutions LLC bought a new stake in HCA Healthcare during the 3rd quarter valued at about $39,000. Activest Wealth Management raised its holdings in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after acquiring an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. boosted its position in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after buying an additional 50 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on HCA shares. Cantor Fitzgerald reissued an "overweight" rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Barclays cut their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. Bank of America reduced their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research report on Monday, January 27th. Morgan Stanley dropped their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a report on Tuesday, December 17th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and issued a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $385.67.

Remove Ads

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Stock Performance

Shares of HCA traded up $0.79 during mid-day trading on Wednesday, reaching $346.52. 315,697 shares of the company's stock were exchanged, compared to its average volume of 1,344,416. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The stock has a market capitalization of $85.31 billion, a PE ratio of 15.77, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The business's fifty day simple moving average is $325.79 and its 200-day simple moving average is $340.25. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm posted $5.90 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were given a dividend of $0.72 per share. The ex-dividend date was Monday, March 17th. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.83%. HCA Healthcare's payout ratio is 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.